The Netherlands Cancer Institute

The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years. Our Dutch account is @hetAVL.

[The Netherlands Cancer Institute @NKI_nl]

We are no longer active on X and moved our activities to Bluesky and LinkedIn. Please follow us there for updates and conversations.
🔗 https://t.co/me5pSruYB0
🔗 https://t.co/MVx1zh0ve4

[The Netherlands Cancer Institute @NKI_nl]

Cancer researcher Leila Akkari receives an Ammodo Science Award for fundamental research. These biannual awards encourage outstanding scientists in their groundbreaking, fundamental research ➡️ https://t.co/SmXpE10QaS

Photo Leila Akkari - ©Florian Braakman

[The Netherlands Cancer Institute @NKI_nl]

Before, we occasionally found a melanoma after surgery, having missed it in the initial diagnosis. Now we can detect 75% of these missed cases before surgery thanks to the confocal microscope, Yannick Elshot discovered. He successfully defended his thesis on March 21 🎓

[The Netherlands Cancer Institute @NKI_nl]

🎓 Less stress: young women who had cervical cancer need fewer screenings after two negative HPV tests, PhD candidate Teska Schuurman discovered. She successfully defended her thesis on March 24.

[The Netherlands Cancer Institute @NKI_nl]

You can compare proteins to a lock, PhD candidate Ida de Vries discovered. With the right key, you can develop targeted therapies. She will defend her thesis on April 3 ➡️ https://t.co/PuMZmTp79s @uniutrecht

[The Netherlands Cancer Institute @NKI_nl]

We’ve loved having Liam Faller at the NKI! As he heads to the UK, we’re sharing this video about this outstanding and likable scientist, whose family inspired his dedication to cancer research.

Best of luck Liam, you will be missed! 💙

https://t.co/wB0npYZCm0

[The Mark Foundation for Cancer Research @TheMarkFdn]

🎉Congratulations to the inaugural recipients of the EACR-Mark Foundation Postdoctoral Fellowship! 🎉
Julie Mazet, Christina Metoikidou, & Martha Zarou will each receive 3 years of funding for their work in leading European cancer research labs. https://t.co/n5kk8JmG3s

[Luca Braccioli @LucaBraccioli]

🚨 Paper Alert 🚨

I'm incredibly proud and excited to announce that our latest research on the chromatin regulatory profile of gastruloids has been published in @Dev_Cell! 🎉
Check out the full paper here: https://t.co/UOpzHFEOHW

@deWitLab, @NKI_nl🙌
🧵👇

[The Netherlands Cancer Institute @NKI_nl]

Can a simple finger-prick at home replace a hospital visit for a blood draw? PhD candidate Marinda Meertens @uniutrecht @NedForInst researched the effectiveness of such an alternative.

She will defend her thesis on Tuesday, March 18 ➡️ https://t.co/GKCFVJ1L76

[The Netherlands Cancer Institute @NKI_nl]

So inspiring to host these international cancer experts at the NKI for the @CancerCoreEU annual meeting! Over 100 members from 7 cancer centers came together over the last 2 days to exchange ideas, align strategies & explore new opportunities for collaboration in cancer research.

[The Netherlands Cancer Institute @NKI_nl]

🎉Piet Borst, former director of the NKI, has been named a Fellow of the @AACR Academy for his advancements to molecular biology and parasitology, including uncovering the mechanisms of surface protein gene relocation in parasites and P-glycoprotein's role in drug resistance

[The Netherlands Cancer Institute @NKI_nl]

As many as one in five cancer patients has to deal with a rare tumor. Rare cancers are more difficult to treat because less research is done on them. A new multidisciplinary RADAR study, led by Wilbert Zwart at the NKI, zooms in on rare cancers.
Read more: https://t.co/AiNX1sU5zT

[The Netherlands Cancer Institute @NKI_nl]

🎓 An even more accurate radiation dose and even fewer errors: Igor Olaciregui @hetAVL @UvA_Amsterdam defends his thesis on research into improved radiation treatment. He will defend his #thesis on March 11 ➡️ https://t.co/iQc3OqIDPO #NKI

[The Netherlands Cancer Institute @NKI_nl]

🎓 Together with colleagues across 7 countries, PhD candidate Itske Fraterman @hetAVL @TilburgU @umcg developed a mobile application to map out the needs and symptoms of patients receiving #immunotherapy. She successfully defended her thesis on February 28. Congratulations Itske!

[The Netherlands Cancer Institute @NKI_nl]

📅 Save the date: on May 14 and 15, the NKI will host the Early Cancer Detection Conference 2025.

Join our conference to explore the latest advances in early cancer detection, from research to clinical application ➡️ https://t.co/zJXUIbmya0
#EarlyCancerDetection #Conference

[The Netherlands Cancer Institute @NKI_nl]

🕘 The clock is ticking. Only 2 days left to apply. Deadline February 28. Don’t miss out!

Join our #PhD program at the Netherlands Cancer Institute in Amsterdam to kick start your career in cancer research ➡️ https://t.co/Ln7xs1zphE

[The Netherlands Cancer Institute @NKI_nl]

In a new study published in @NatureComms, researchers from the NKI developed an AI model called Multi-Modal Response Prediction (MRP). This model can help physicians predict how breast cancer patients will respond to neoadjuvant therapy. More ➡️ https://t.co/XIwMCHuwPd

[The Netherlands Cancer Institute @NKI_nl]

“It is crucial to actively involve cancer patients in the development of decision aids from day 1” says Ellen Engelhardt. With the Eveline Bleiker research group she develops tools to help women decide on preventative treatment preferences. #WorldCancerDay https://t.co/jP9xxkZmXB

[STOA Panel @EP_ScienceTech]

Today is #WorldCancerDay

👉Interview with @myESMO Lifetime Achievement Award winner John Haanen of @LUMC_Leiden & @NKI_nl:

'Building a hopeful future for #oncology: using people’s own cells in the fight against #cancer'

🔗https://t.co/qt8IvejCBj
@1989_mariab @EP_EPRS

[The Netherlands Cancer Institute @NKI_nl]

Such great news for NKI spinoff company Sirius Medical on #WorldCancerDay. Their technology helps surgeons with precise surgical removal of breast cancers. Congratulations with this step towards improving cancer care!

[Sirius Medical @SiriusMedical]

🚀 Exciting News from Sirius Medical!

On #WorldCancerDay, we’re happy to announce €10M in scale-up funding led by Invest-NL and NextGen Ventures, with support from De Groot Family Office, Brabantse Ontwikkelings Maatschappij (BOM), Holland Capital, Curie Capital BV, and more.

🎙️ “We are proud of the Sirius Medical team and grateful for the trust of our investors. This investment enables us to continue making a meaningful difference for women with breast cancer,” says Bram Schermers, CEO of Sirius Medical, "And this is just the beginning, we have more exciting news coming up soon."

This investment enables Sirius Medical to enhance the #Pintuition Surgical Marker Navigation platform and extend our global reach to new markets.

Read the full press release here: https://t.co/mELkl2fAea

🌐 https://t.co/Ghr2BAUlf2 | #HealthcareInnovation #BreastCancerCare #SiriusPintuition #WorldCancerDay